• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Leucocyte migration inhibition and leucocyte adherence inhibition studies, using ferritin as 'antigen', in patients with malignant lymphoma.

作者信息

Bruce L, Grail A, Hancock B W

出版信息

Hematol Oncol. 1984 Apr-Jun;2(2):169-77. doi: 10.1002/hon.2900020206.

DOI:10.1002/hon.2900020206
PMID:6745868
Abstract

Isoelectric focusing of ferritin prepared from three spleens involved by Hodgkin's disease demonstrated only minor differences from normal spleen ferritin. The leucocyte migration inhibition (LMI) and leucocyte adherence inhibition (LAI) assays were used to assess sensitization to Hodgkin's disease spleen ferritin and its component acidic and basic isoferritins in patients with malignant lymphoma compared to patients with other malignancies and control subjects. A difference in response to ferritin was demonstrated in both tests with patients with malignant lymphoma compared to controls, and in LMI test compared to patients with other malignancies. There were also significant differences in responses in, patients with malignant lymphoma compared to controls, against acidic and basic isoferritins in both tests, in lymphoma patients versus patients with other malignancies against acidic isoferritins in both tests, lymphoma versus other malignancy against basic isoferritins in the LMI test only. However, no significant differences, within each group, between responses with acidic and with basic isoferritins were demonstrated, and there was no correlation between individual patients' responses in the two tests.

摘要

相似文献

1
Leucocyte migration inhibition and leucocyte adherence inhibition studies, using ferritin as 'antigen', in patients with malignant lymphoma.
Hematol Oncol. 1984 Apr-Jun;2(2):169-77. doi: 10.1002/hon.2900020206.
2
Ferritin, a sensitizing substance in the leucocyte migration inhibition test in patients with malignant lymphoma.铁蛋白,恶性淋巴瘤患者白细胞游走抑制试验中的一种致敏物质。
Br J Haematol. 1979 Oct;43(2):223-33. doi: 10.1111/j.1365-2141.1979.tb03745.x.
3
Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.鉴定白血病相关抑制活性为酸性异铁蛋白。酸性异铁蛋白在粒细胞和巨噬细胞产生中的调节作用。
J Exp Med. 1981 Jun 1;153(6):1426-44. doi: 10.1084/jem.153.6.1426.
4
[Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].[利用人胎儿制剂对癌症患者进行白细胞迁移抑制和白细胞黏附抑制(LMI和LAI检测)]
Acta Biol Med Ger. 1978;37(11-12):1747-57.
5
Cellular immunity to Hodgkin's splenic tissue measured by leucocyte migration inhibition.通过白细胞游走抑制测定对霍奇金脾脏组织的细胞免疫。
Br Med J. 1976 Mar 6;1(6009):556-7. doi: 10.1136/bmj.1.6009.556.
6
Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin's and non-Hodgkin's lymphoma patients, with the leukocyte adherence inhibition assay.
Int J Cancer. 1977 Mar 15;19(3):356-63. doi: 10.1002/ijc.2910190312.
7
Immunological reactivity of serum ferritin in patients with malignancy.
Tumori. 1985 Dec 31;71(6):547-54. doi: 10.1177/030089168507100606.
8
Isoferritins in acute leukaemia.急性白血病中的异铁蛋白
Br J Cancer. 1977 May;35(5):635-42. doi: 10.1038/bjc.1977.99.
9
Sensitisation to Hodgkin's disease spleen tissue in patients with malignant lymphoma: follow-up study.恶性淋巴瘤患者对霍奇金病脾脏组织的致敏作用:随访研究
Br Med J. 1976 Aug 7;2(6031):351-2. doi: 10.1136/bmj.2.6031.351.
10
Common epitopes in human isoferritins characterized by murine monoclonal antibodies.用鼠单克隆抗体鉴定的人异铁蛋白中的共同表位
J Biochem. 1986 Jan;99(1):269-79. doi: 10.1093/oxfordjournals.jbchem.a135469.